Blood test to help diagnose ovarian cancer sooner
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study checks whether a special blood test (circulating tumor DNA) can help find ovarian cancer when it’s suspected. It may help doctors diagnose more accurately and sooner, so the right treatment can start sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You currently have suspected ovarian cancer (ovarian growth found or strong concern it could be cancer).
- You can understand the study and give informed consent.
- You have never been told you had ovarian cancer before.
- If you cannot give consent, you cannot join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test that looks for DNA changes to help detect ovarian cancer earlier. You would give a blood sample before your planned surgery or biopsy, and researchers will compare the test results with your pathology report to see how accurate it is.
This study looks at tiny molecules in your blood (called microRNAs) to see if they can help doctors identify and manage malignant ovarian germ cell tumors. By giving a blood sample at diagnosis, you may help improve future detection and treatment for this rare cancer.
This study is testing a blood test that may help find ovarian cancer earlier in people with BRCA1 or BRCA2 gene changes. It involves giving blood samples before and after surgery to remove the ovaries and fallopian tubes, or over several years if you've had a precancerous lesion found.
This study tests genetic (DNA) information to help doctors identify ovarian or uterine (endometrial) cancer sooner. You may be asked to do this around the time of planned surgery, when tissue is removed and can be checked for genetic clues.
This study checks whether a sample of fluid from the uterus (uterine lavage) can help detect ovarian or fallopian tube cancer. You may join if you are having certain gynecologic surgeries or, in a smaller group, you have a BRCA1/2 mutation.
This study checks whether a blood test (ctDNA) can show how well ovarian, fallopian tube, or primary peritoneal cancer treatment is working. If the test reliably reflects response, it could help doctors adjust treatment earlier and more precisely.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.